Posts

Key players in the COPD and Asthma Devices Market face price competition from the local device manufacturers

Global COPD and asthma devices market  is expected to reach $41,355.2 million by 2022, according to a new report by Allied Market Research . The drug powder inhaler was the highest revenue-generating segment, accounting for over half of the share in 2015. This segment is expected to maintain its dominance throughout the forecast period. Download the Sample Report @  https://www.alliedmarketresearch.com/request-sample/579?utm_source=Blogger&utm_medium=Niranjan The factors hampering the market growth include environmental concerns associated with metered dose inhalers (MDI) and high cost of selected inhalation devices. Regulatory authorities such as U.S. food and drug administration (USFDA) across several regions have banned the production and sales of MDIs, as they release environmentally hazardous gases such as chlorofluorocarbon (CFC) and hydrofluoroalkanes (HFA). Thus, soft mist inhalers (SMIs) and nebulizers are expected to replace MDIs for the treatment of resp...

Drug-Device Combination Products

The drug-device combination products are defined as a medical device and a pharmaceutical drug that are used in combination for the treatment of various chronic disorders. The medical device is used to deliver the drug at the site of action in a patient's body. The active pharmaceutical ingredient is mostly mixed chemically or physically, and the resulting solution is used. These combination products are used to treat as well as diagnose clinical conditions. Download the Sample Report @  https://www.alliedmarketresearch.com/request-sample/667?utm_source=Blogger&utm_medium=Niranjan According to a new report published by Allied Market Research, titled,  Drug-Device Combination Products Market,  by Product, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2018-2025," the market was valued at $81,374 million in 2017, and is projected to reach $139,193 million in 2025, registering a CAGR of 6.9% from 2018 to 2025. Increase in incidence ...

Medical imaging consists of different types of diagnostic devices

Medical imaging refers to the use of different imaging modalities to obtain visual representations of the interior of a body for diagnostic purposes. The different imaging modalities utilized include ultrasound, computed tomography, magnetic resonance imaging, and others. The medical imaging market has gained prominence in the recent years, owing to rapid technological advancements, rise in incidence of chronic disorders, increase in number of diagnostic imaging procedures, and surge in awareness for early diagnosis of diseases. However, high cost of medical imaging systems and shortage of helium impede the market growth. Download the Sample Report @  https://www.alliedmarketresearch.com/request-sample/4544?utm_source=Blogger&utm_medium=Niranjan New Zealand medical imaging services market is expected to reach $500 million by 2025, registering a CAGR of 7.3% from 2019 to 2025, in terms of value. Depending on application, the breast health segment is expected to exhibit t...

Technological Advancement in Bone grafts and substitutes

Bone grafts are implantable materials that promote bone healing, bone formation, and osseous reconstruction. Download the Sample Report @  https://www.alliedmarketresearch.com/request-sample/1774?utm_source=Blogger&utm_medium=Niranjan Increase in incidence of musculoskeletal conditions, advancements in medical technology leading to a shift from autograft to allograft, rise in preference for biocompatible bone grafts are the key factors that contribute toward the growth of the global bone grafts and substitutes market. In addition, increase in cases of lifestyle disorders such as diabetes and obesity add to the risk of developing degenerative joint diseases that further fuels the growth of the market. However, the major restraints of this market are ethical issues related to bone grafting and high cost of surgeries. The market was valued at $2,690 million in 2017, and is expected to reach $3,912 million by 2025, growing at a CAGR of 4.8% from 2018 to 2025. Cell based m...

Urinary Incontinence Devices Market Expected to reach $3,411 Million, Globally,by 2023

The Urinary Incontinence devices market was valued at $1,611 million in 2016, and is projected to reach $3,411 million by 2023, growing at a CAGR of 11.3% from 2017 to 2023. The internal urinary incontinence devices segment accounted for three-fifths share of the market in 2016. Download the Sample Report @  https://www.alliedmarketresearch.com/request-sample/4550?utm_source=Blogger&utm_medium=Niranjan Urinary incontinence is a highly prevalent condition and is considered to be an underreported problem that increases with age that affects nearly 50% of the geriatric population. Urinary incontinence is categorized into four major types namely stress urinary incontinence, urge urinary incontinence, mixed urinary incontinence, and functional urinary incontinence. Stress urine leakage is associated with increased abdominal pressure from laughing, sneezing, coughing, climbing stairs, or other physical factors that assert stress on the abdominal cavity. Whereas, urge incontinen...

RNA Based Therapeutics Market Overview

RNA Based Therapeutics Market Report,  published by Allied Market Research, forecasts that the global market is expected to garner $1.2 billion by 2020, registering a CAGR of 28.4% during the period 2014-2020. Due to its ability to render targeted solutions for chronic diseases such as cancer, AIDS, rare genetic disorders, and certain cardiovascular conditions, RNA based therapeutics is expected to significantly impact the global pharmaceutical industry. Download the Sample Report @  http://bit.ly/2KTTCdM The large scale funding from public and private sector, growing interest of pharmaceuticals and biotech giants for developing novel delivery technology, and anticipated saving in healthcare expenditure are propelling the growth of RNA therapeutics market. Moreover, the platform technologies such as RNAi and antisense have enabled researchers to accelerate their research activities by defining gene sequences for chronic diseases. Companies have widened the research focus...

Latest Research on Biosimilars

Global Biosimilars Market  (Follow-on-Biologics) by Types (Human growth hormone, Erythropoietin, Monoclonal antibodies, Insulin, Interferon, Granulocyte-Colony Stimulating Factor, Peptide), Application (Blood disorders, Oncology diseases, Growth hormone deficiencies) is projected to grow at a CAGR of 49.1% from 2015 to 2020, according to new research published by Allied Market Research. Download the Sample Report @  http://bit.ly/2KQLrPb Europe would continue to dominate the market while Asia Pacific would emerge as fastest growing region over the forecast period. Recent approval of Zarxio (filgrastim-sndz) as first biosimilar by U.S. FDA has opened new opportunities for biosimilar manufactures. Patents for number of blockbuster bio-pharmaceuticals have either expired or are on the verge of expiration, which is majorly driving the growth of biosimilars industry. Changes in regulatory guidelines and convenient biosimilar drug approval processes have a major impact on th...